AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: HCWB
Report Date: 2026-04-01
Full Report: https://amaly.io/stock/HCWB

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: BB
Description: HCWB, a clinical-stage biotechnology company, demonstrates strong financial metrics in debt and liquidity but faces challenges with elevated interest income ratio exceeding Shariah thresholds. Business activities in biologics R&D are permissible, with no non-compliant core operations identified. Overall, the stock is classified as non-compliant due to index exclusions, though purification can mitigate impermissible income. ESG factors align well with Islamic principles, showing low risk in governance and social responsibility. Investors should monitor future financials for potential compliance improvements.

Primary Compliance Concerns:
- Interest income ratio of 21.2% exceeds 5% threshold across all standards
- Exclusion from all major Shariah indices due to financial screening failures

Purification Requirement: 21.20%
Index Inclusion: Not included in any major Shariah-compliant indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 8.6%
Liquidity Ratio: 0.0%
Interest Income Ratio: 21.2%
Purification Required: 21.20%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: EXCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 0 of 4
Last Verified: 2025-12-01

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q3 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-14T12:00:00Z

---
Full interactive report: https://amaly.io/stock/HCWB
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.